Society guideline links: Cryptococcosis

Introduction — This topic includes links to society and government-sponsored guidelines from selected countries and regions around the world. We will update these links periodically; newer versions of some guidelines may be available on each society's website. Some societies may require users to log in to access their guidelines.

The recommendations in the following guidelines may vary from those that appear in UpToDate topic reviews. Readers who are looking for UpToDate topic reviews should use the UpToDate search box to find the relevant content.

Links to related guidelines are provided separately. (See "Society guideline links: Opportunistic infections in adults and adolescents with HIV".)

International

●World Health Organization (WHO): Guidelines for the diagnosis, prevention, and management of cryptococcal disease in HIV-infected adults, adolescents, and children – Supplement to the 2016 consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection (2018)

●WHO: Guidelines for managing advanced HIV disease and rapid initiation of antiretroviral therapy (2017)

United States

●American Academy of Pediatrics (AAP): Red Book – Cryptococcus neoformans and Cryptococcus gattii infections (cryptococcosis) (2021)

●Centers for Disease Control and Prevention (CDC), National Institutes of Health (NIH), and HIV Medicine Association (HIVMA) of the Infectious Diseases Society of America (IDSA): Guidelines for the prevention and treatment of opportunistic infections in adults and adolescents with HIV – Cryptococcosis (updated 2021)

●NIH, CDC, HIVMA of the IDSA, and Pediatric Infectious Diseases Society (PIDS): Guidelines for the prevention and treatment of opportunistic infections in HIV-exposed and HIV-infected children – Cryptococcosis (2013)

●ATS: Official statement on the treatment of fungal infections in adult pulmonary and critical care patients – Cryptococcosis (2011)

●IDSA: Clinical practice guidelines for the management of cryptococcal disease, update (ARCHIVED; published 2010)

Europe

●European AIDS Clinical Society (EACS): Guidelines – Opportunistic infections (2020)

●European Conference on Infections in Leukemia (ECIL): Recommendations for the use of biological markers for the diagnosis of invasive fungal diseases in leukemic patients and hematopoietic SCT recipients – Cryptococcus Ag (2012)

United Kingdom

●British Society for Medical Mycology (BSMM): Best practice recommendations for the diagnosis of serious fungal diseases (2015)

●British HIV Association (BHIVA) and British Infection Association (BIA): Guidelines for the treatment of opportunistic infection in HIV-seropositive individuals (2011)

Australia–New Zealand

●Royal Australasian College of Physicians (RACP): Consensus guidelines for the diagnosis and management of cryptococcosis and rare yeast infections in the haematology/oncology setting (2021)